BioCentury
ARTICLE | Clinical News

Lytixar: Phase I/IIa start

May 31, 2010 7:00 AM UTC

Next half, Lytix will begin a placebo-controlled, dose-escalation, Swedish Phase I/IIa trial to evaluate Lytixar in patients who are nasal carriers of MRSA. ...